002907 华森制药
已收盘 12-29 15:00:00
资讯
新帖
简况
华森制药（002907）披露公司药品生产许可证变更公告，12月26日股价下跌2.18%
证券之星 · 12-26 22:55
华森制药（002907）披露公司药品生产许可证变更公告，12月26日股价下跌2.18%
华森制药最新公告：收到注射用奥美拉唑钠药品再注册批准通知书
证券之星 · 12-23
华森制药最新公告：收到注射用奥美拉唑钠药品再注册批准通知书
华森制药：12月19日高管游洪涛减持股份合计29.54万股
证券之星 · 12-22
华森制药：12月19日高管游洪涛减持股份合计29.54万股
12月19日华森制药现2笔折价10.78%的大宗交易 合计成交400.86万元
证券之星 · 12-19
12月19日华森制药现2笔折价10.78%的大宗交易 合计成交400.86万元
华森制药：12月12日高管游洪涛减持股份合计14.5万股
证券之星 · 12-15
华森制药：12月12日高管游洪涛减持股份合计14.5万股
12月4日华森制药发布公告，股东减持51.4万股
证券之星 · 12-04
12月4日华森制药发布公告，股东减持51.4万股
华森制药：12月1日高管游洪涛减持股份合计13.8万股
证券之星 · 12-02
华森制药：12月1日高管游洪涛减持股份合计13.8万股
12月1日华森制药现1笔折价10.5%的大宗交易 合计成交201.2万元
证券之星 · 12-01
12月1日华森制药现1笔折价10.5%的大宗交易 合计成交201.2万元
华森制药：11月26日高管游洪涛减持股份合计13.6万股
证券之星 · 11-27
华森制药：11月26日高管游洪涛减持股份合计13.6万股
华森制药：11月24日高管游洪涛减持股份合计14.1万股
证券之星 · 11-25
华森制药：11月24日高管游洪涛减持股份合计14.1万股
11月24日华森制药现1笔折价11.62%的大宗交易 合计成交200.5万元
证券之星 · 11-24
11月24日华森制药现1笔折价11.62%的大宗交易 合计成交200.5万元
华森制药（002907）披露公司产品完成境内生产药品备案，11月20日股价上涨0.06%
证券之星 · 11-20
华森制药（002907）披露公司产品完成境内生产药品备案，11月20日股价上涨0.06%
华森制药(002907.SZ)甲磺酸雷沙吉兰片完成境内生产药品备案
智通财经 · 11-20
华森制药(002907.SZ)甲磺酸雷沙吉兰片完成境内生产药品备案
华森制药（002907）披露公司药品生产许可证变更公告，11月18日股价下跌1.36%
证券之星 · 11-18
华森制药（002907）披露公司药品生产许可证变更公告，11月18日股价下跌1.36%
股市必读：11月14日华森制药现1笔折价11.88%的大宗交易 合计成交200.17万元
证券之星 · 11-17
股市必读：11月14日华森制药现1笔折价11.88%的大宗交易 合计成交200.17万元
华森制药：11月12日高管游洪涛减持股份合计113.37万股
证券之星 · 11-13
华森制药：11月12日高管游洪涛减持股份合计113.37万股
华森制药(002907.SZ)获得特殊医学用途配方食品注册证书
智通财经 · 11-12
华森制药(002907.SZ)获得特殊医学用途配方食品注册证书
股市必读：华森制药（002907）11月11日披露最新机构调研信息
证券之星 · 11-12
股市必读：华森制药（002907）11月11日披露最新机构调研信息
华森制药：疆亘资本、佛山抱石商业投资有限公司等多家机构于11月11日调研我司
证券之星 · 11-11
华森制药：疆亘资本、佛山抱石商业投资有限公司等多家机构于11月11日调研我司
华森制药：11月7日高管游洪涛减持股份合计13.7万股
证券之星 · 11-10
华森制药：11月7日高管游洪涛减持股份合计13.7万股
加载更多
公司概况
公司名称：
重庆华森制药股份有限公司
所属行业：
医药制造业
上市日期：
2017-10-20
主营业务：
重庆华森制药股份有限公司的主营业务是中成药、化学药的研发、生产和销售。公司的主要产品是耳鼻喉科用药、消化系统用药、精神神经系统用药、其他领域用药、医药商业、医药零售、其他业务。
发行价格：
4.53
{"stockData":{"symbol":"002907","market":"SZ","secType":"STK","nameCN":"华森制药","latestPrice":15.04,"timestamp":1766991801000,"preClose":15.23,"halted":0,"volume":2007800,"delay":0,"changeRate":-0.0125,"floatShares":300000000,"shares":418000000,"eps":0.1787,"marketStatus":"已收盘","change":-0.19,"latestTime":"12-29 15:00:00","open":15.13,"high":15.2,"low":15.03,"amount":30257700,"amplitude":0.0112,"askPrice":15.05,"askSize":46,"bidPrice":15.04,"bidSize":175,"shortable":0,"etf":0,"ttmEps":0.1787,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1767058200000},"marketStatusCode":5,"adr":0,"adjPreClose":15.23,"symbolType":"stock","openAndCloseTimeList":[[1766971800000,1766979000000],[1766984400000,1766991600000]],"highLimit":16.75,"lowLimit":13.71,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":417596314,"isCdr":false,"pbRate":3.77,"roa":"--","peRate":84.163402,"roe":"4.31%","epsLYR":0.1837,"committee":0.718943,"marketValue":6281000000,"turnoverRate":0.0067,"status":1,"floatMarketCap":4511000000},"requestUrl":"/m/hq/s/002907","defaultTab":"news","newsList":[{"id":"2594947752","title":"华森制药（002907）披露公司药品生产许可证变更公告，12月26日股价下跌2.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594947752","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594947752?lang=zh_cn&edition=full","pubTime":"2025-12-26 22:55","pubTimestamp":1766760913,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，华森制药报收于15.23元，较前一交易日下跌2.18%，最新总市值为63.6亿元。该股当日开盘15.45元，最高15.45元，最低15.12元，成交额达6714.44万元，换手率为1.47%。本次变更有助于提高公司产能利用率，短期内对公司业绩无重大影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600036937.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002907","BK0239"],"gpt_icon":0},{"id":"2593496845","title":"华森制药最新公告：收到注射用奥美拉唑钠药品再注册批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2593496845","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593496845?lang=zh_cn&edition=full","pubTime":"2025-12-23 17:43","pubTimestamp":1766483030,"startTime":"0","endTime":"0","summary":"华森制药(002907.SZ)公告称，公司近日收到重庆市药品监督管理局核准签发的关于公司产品注射用奥美拉唑钠的《药品再注册批准通知书》。该产品为上消化道出血经典用药，临床必需，为国家医保目录产品，获多项指南共识推荐。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300028286.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002907","BK0239"],"gpt_icon":0},{"id":"2593480388","title":"华森制药：12月19日高管游洪涛减持股份合计29.54万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2593480388","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593480388?lang=zh_cn&edition=full","pubTime":"2025-12-22 21:02","pubTimestamp":1766408541,"startTime":"0","endTime":"0","summary":"证券之星消息，根据12月22日市场公开信息、上市公司公告及交易所披露数据整理，华森制药（002907）最新董监高及相关人员股份变动情况：2025年12月19日公司董事,高管游洪涛共减持公司股份29.54万股，占公司总股本为0.0707%。变动期间公司股价上涨0.86%，12月19日当日收盘报15.21元。华森制药近半年内的董监高及核心技术人员增减持详情如下：华森制药的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122200031931.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002907"],"gpt_icon":0},{"id":"2592157150","title":"12月19日华森制药现2笔折价10.78%的大宗交易 合计成交400.86万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592157150","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592157150?lang=zh_cn&edition=full","pubTime":"2025-12-19 17:41","pubTimestamp":1766137305,"startTime":"0","endTime":"0","summary":"证券之星消息，12月19日华森制药发生大宗交易，交易数据如下：近三个月该股共发生16笔大宗交易，合计成交4.3万手，折价成交16笔。该股近期无解禁股上市。截至2025年12月19日收盘，华森制药(002907)报收于15.21元，上涨0.86%，换手率0.47%，成交量1.41万手，成交额2133.74万元。该股近半年内有股东持股变动，合计净减持969.35万股，股东增减持明细如下表：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121900026924.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002907","BK0239"],"gpt_icon":0},{"id":"2591649168","title":"华森制药：12月12日高管游洪涛减持股份合计14.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2591649168","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591649168?lang=zh_cn&edition=full","pubTime":"2025-12-15 21:02","pubTimestamp":1765803741,"startTime":"0","endTime":"0","summary":"证券之星消息，根据12月15日市场公开信息、上市公司公告及交易所披露数据整理，华森制药（002907）最新董监高及相关人员股份变动情况：2025年12月12日公司董事,高管游洪涛共减持公司股份14.5万股，占公司总股本为0.0347%。变动期间公司股价上涨0.91%，12月12日当日收盘报15.52元。华森制药近半年内的董监高及核心技术人员增减持详情如下：华森制药的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500032681.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002907"],"gpt_icon":0},{"id":"2588885979","title":"12月4日华森制药发布公告，股东减持51.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2588885979","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588885979?lang=zh_cn&edition=full","pubTime":"2025-12-04 19:01","pubTimestamp":1764846091,"startTime":"0","endTime":"0","summary":"证券之星消息，12月4日华森制药发布公告《华森制药:关于控股股东及其一致行动人持股变动触及1%整数倍的公告》，其股东上海添橙投资管理有限公司-添橙添利一号私募证券投资基金于2025年11月7日至2025年12月3日间合计减持51.4万股，占公司目前总股本的0.1231%，变动期间该股股价下跌1.29%，截止12月3日收盘报16.08元。股东增减持详情见下表：根据华森制药2025年三季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400032300.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002907","BK0239"],"gpt_icon":0},{"id":"2588537270","title":"华森制药：12月1日高管游洪涛减持股份合计13.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2588537270","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588537270?lang=zh_cn&edition=full","pubTime":"2025-12-02 21:02","pubTimestamp":1764680566,"startTime":"0","endTime":"0","summary":"证券之星消息，根据12月2日市场公开信息、上市公司公告及交易所披露数据整理，华森制药（002907）最新董监高及相关人员股份变动情况：2025年12月1日公司董事,高管游洪涛共减持公司股份13.8万股，占公司总股本为0.033%。变动期间公司股价上涨0.56%，12月1日当日收盘报16.29元。华森制药近半年内的董监高及核心技术人员增减持详情如下：华森制药的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200037317.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002907","BK0239"],"gpt_icon":0},{"id":"2588723008","title":"12月1日华森制药现1笔折价10.5%的大宗交易 合计成交201.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588723008","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588723008?lang=zh_cn&edition=full","pubTime":"2025-12-01 17:42","pubTimestamp":1764582143,"startTime":"0","endTime":"0","summary":"证券之星消息，12月1日华森制药发生大宗交易，交易数据如下：大宗交易成交价格14.58元，相对当日收盘价折价10.5%，成交13.8万股，成交金额201.2万元，买方营业部为机构专用，卖方营业部为华泰证券股份有限公司宜都长江大道证券营业部。近三个月该股共发生9笔大宗交易，合计成交1.82万手，折价成交9笔。截至2025年12月1日收盘，华森制药报收于16.29元，上涨0.56%，换手率0.57%，成交量1.71万手，成交额2792.05万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100022415.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002907"],"gpt_icon":0},{"id":"2586228348","title":"华森制药：11月26日高管游洪涛减持股份合计13.6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2586228348","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586228348?lang=zh_cn&edition=full","pubTime":"2025-11-27 21:01","pubTimestamp":1764248505,"startTime":"0","endTime":"0","summary":"证券之星消息，根据11月27日市场公开信息、上市公司公告及交易所披露数据整理，华森制药（002907）最新董监高及相关人员股份变动情况：2025年11月26日公司董事,高管游洪涛共减持公司股份13.6万股，占公司总股本为0.0326%。变动期间公司股价下跌0.37%，11月26日当日收盘报16.31元。华森制药近半年内的董监高及核心技术人员增减持详情如下：华森制药的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700035974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002907","BK0239"],"gpt_icon":0},{"id":"2586473278","title":"华森制药：11月24日高管游洪涛减持股份合计14.1万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2586473278","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586473278?lang=zh_cn&edition=full","pubTime":"2025-11-25 21:02","pubTimestamp":1764075733,"startTime":"0","endTime":"0","summary":"证券之星消息，根据11月25日市场公开信息、上市公司公告及交易所披露数据整理，华森制药（002907）最新董监高及相关人员股份变动情况：2025年11月24日公司董事,高管游洪涛共减持公司股份14.1万股，占公司总股本为0.0338%。变动期间公司股价上涨1.84%，11月24日当日收盘报16.09元。华森制药近半年内的董监高及核心技术人员增减持详情如下：华森制药的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112500036683.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002907","BK0239"],"gpt_icon":0},{"id":"2585645000","title":"11月24日华森制药现1笔折价11.62%的大宗交易 合计成交200.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585645000","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585645000?lang=zh_cn&edition=full","pubTime":"2025-11-24 17:41","pubTimestamp":1763977302,"startTime":"0","endTime":"0","summary":"证券之星消息，11月24日华森制药发生大宗交易，交易数据如下：大宗交易成交价格14.22元，相对当日收盘价折价11.62%，成交14.1万股，成交金额200.5万元，买方营业部为华泰证券股份有限公司广东分公司，卖方营业部为华泰证券股份有限公司宜都长江大道证券营业部。近三个月该股共发生7笔大宗交易，合计成交1.54万手，折价成交7笔。截至2025年11月24日收盘，华森制药报收于16.09元，上涨1.84%，换手率0.74%，成交量2.22万手，成交额3561.91万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400022240.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002907","BK0239"],"gpt_icon":0},{"id":"2584522130","title":"华森制药（002907）披露公司产品完成境内生产药品备案，11月20日股价上涨0.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584522130","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584522130?lang=zh_cn&edition=full","pubTime":"2025-11-20 22:22","pubTimestamp":1763648544,"startTime":"0","endTime":"0","summary":"截至2025年11月20日收盘，华森制药报收于16.35元，较前一交易日上涨0.06%，最新总市值为68.28亿元。公司近日发布公告称，重庆华森制药股份有限公司已完成甲磺酸雷沙吉兰片境内生产药品备案，备案号为渝备2025047469，批准文号为国药准字H20243081。公司为该药品的上市许可持有人和生产企业。甲磺酸雷沙吉兰片为国家医保乙类药品，适用于帕金森病患者治疗，已纳入多部临床指南，并在2024年第十批集采中中标。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000038237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002907"],"gpt_icon":0},{"id":"2584184363","title":"华森制药(002907.SZ)甲磺酸雷沙吉兰片完成境内生产药品备案","url":"https://stock-news.laohu8.com/highlight/detail?id=2584184363","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584184363?lang=zh_cn&edition=full","pubTime":"2025-11-20 17:08","pubTimestamp":1763629720,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华森制药(002907.SZ)公告，公司近日从国家药品监督管理局网站查询获知公司产品甲磺酸雷沙吉兰片完成境内生产药品备案(药品说明书适老化申请)，并于国家药监局网站公示备案信息。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1371600.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"华森制药(002907.SZ)甲磺酸雷沙吉兰片完成境内生产药品备案","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002907"],"gpt_icon":0},{"id":"2584795536","title":"华森制药（002907）披露公司药品生产许可证变更公告，11月18日股价下跌1.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584795536","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584795536?lang=zh_cn&edition=full","pubTime":"2025-11-18 22:22","pubTimestamp":1763475749,"startTime":"0","endTime":"0","summary":"截至2025年11月18日收盘，华森制药报收于16.62元，较前一交易日下跌1.36%，最新总市值为69.4亿元。该股当日开盘16.79元，最高17.11元，最低16.53元，成交额达8155.74万元，换手率为1.63%。公司近日发布公告称，重庆华森制药股份有限公司近日收到重庆市药品监督管理局颁发的《药品生产许可证》，变更内容为延续受托生产孟鲁司特钠颗粒的有效期至2026年3月2日。本次变更有助于提高公司产能利用率，短期内对公司业绩无重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111800039916.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002907"],"gpt_icon":0},{"id":"2584698177","title":"股市必读：11月14日华森制药现1笔折价11.88%的大宗交易 合计成交200.17万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584698177","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584698177?lang=zh_cn&edition=full","pubTime":"2025-11-17 02:11","pubTimestamp":1763316673,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，华森制药报收于17.34元，上涨2.12%，换手率3.82%，成交量11.44万手，成交额1.97亿元。来自交易信息汇总：同日发生一笔折价11.88%的大宗交易，合计成交200.17万元，反映部分股东减持意愿较强。交易信息汇总资金流向11月14日主力资金净流入1409.16万元；游资资金净流出1202.09万元；散户资金净流出207.07万元。大宗交易11月14日华森制药现1笔折价11.88%的大宗交易，合计成交200.17万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700000778.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002907","BK0239"],"gpt_icon":0},{"id":"2583598877","title":"华森制药：11月12日高管游洪涛减持股份合计113.37万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2583598877","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583598877?lang=zh_cn&edition=full","pubTime":"2025-11-13 21:02","pubTimestamp":1763038961,"startTime":"0","endTime":"0","summary":"证券之星消息，根据11月13日市场公开信息、上市公司公告及交易所披露数据整理，华森制药（002907）最新董监高及相关人员股份变动情况：2025年11月12日公司董事,高管游洪涛共减持公司股份113.37万股，占公司总股本为0.2715%。变动期间公司股价上涨1.93%，11月12日当日收盘报16.93元。华森制药近半年内的董监高及核心技术人员增减持详情如下：华森制药的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300040356.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002907","BK0239"],"gpt_icon":0},{"id":"2582532948","title":"华森制药(002907.SZ)获得特殊医学用途配方食品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2582532948","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582532948?lang=zh_cn&edition=full","pubTime":"2025-11-12 17:16","pubTimestamp":1762938967,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华森制药(002907.SZ)发布公告，公司于近日收到国家市场监督管理总局核准签发的关于公司产品的《特殊医学用途配方食品注册证书》，商品名称：甘亦美®，适用人群：10岁以上需要限制脂肪摄入、消化吸收障碍等医学状况下的人群。该批件是公司继特易美®产品后获得的第二个特殊医学用途配方食品注册证书，也代表着公司在特殊医学用途配方食品领域的研发实力和市场竞争力得到了进一步认可与提升。该批件的获得进一步增加公司的产品储备，有助于提升公司的市场竞争力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1368316.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002907","BK0239"],"gpt_icon":0},{"id":"2582392886","title":"股市必读：华森制药（002907）11月11日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2582392886","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582392886?lang=zh_cn&edition=full","pubTime":"2025-11-12 04:04","pubTimestamp":1762891453,"startTime":"0","endTime":"0","summary":"截至2025年11月11日收盘，华森制药报收于16.61元，上涨0.67%，换手率0.87%，成交量2.61万手，成交额4315.65万元。来自机构调研要点：华森制药通过控股奥睿药业，已拥有7个1.1类创新药在研项目，注射用盐酸ORIC-1940正开展Ia/Ib期临床研究。公司计划在2025年底及2026年第一季度分别提交另两个项目的IND申请。利润方面，第三季度归母净利润及扣非归母净利润同比分别下降32.37%和70.50%，主因研发费用上升及补缴企业所得税所致。新产品陆续上市，预计将形成新的利润增长点。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200002996.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002907","BK0239"],"gpt_icon":0},{"id":"2582036529","title":"华森制药：疆亘资本、佛山抱石商业投资有限公司等多家机构于11月11日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2582036529","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582036529?lang=zh_cn&edition=full","pubTime":"2025-11-11 20:02","pubTimestamp":1762862577,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年11月11日华森制药发布公告称疆亘资本投资经理 胡保才、佛山抱石商业投资有限公司行业分析师 苏建鸿、浙江省江山市招商局办公室主任 毛呈程于2025年11月11日调研我司。在大健康领域方面，以引入特医食品研发项目为契机，基于制药企业特有优势，拓展特医食品赛道，短期内对补充公司营业收入及现金流有着积极的影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100035916.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002907"],"gpt_icon":0},{"id":"2582879247","title":"华森制药：11月7日高管游洪涛减持股份合计13.7万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2582879247","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582879247?lang=zh_cn&edition=full","pubTime":"2025-11-10 21:02","pubTimestamp":1762779740,"startTime":"0","endTime":"0","summary":"证券之星消息，根据11月10日市场公开信息、上市公司公告及交易所披露数据整理，华森制药（002907）最新董监高及相关人员股份变动情况：2025年11月7日公司董事,高管游洪涛共减持公司股份13.7万股，占公司总股本为0.0328%。变动期间公司股价上涨0.31%，11月7日当日收盘报16.34元。华森制药近半年内的董监高及核心技术人员增减持详情如下：华森制药的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000032362.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002907"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1767006155648,"stockEarnings":[{"period":"1week","weight":0.0013},{"period":"1month","weight":-0.0662},{"period":"3month","weight":-0.0651},{"period":"6month","weight":-0.0729},{"period":"1year","weight":0.1566},{"period":"ytd","weight":0.1771}],"compareEarnings":[{"period":"1week","weight":0.0188},{"period":"1month","weight":0.0257},{"period":"3month","weight":0.0354},{"period":"6month","weight":0.1575},{"period":"1year","weight":0.1664},{"period":"ytd","weight":0.1826}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"重庆华森制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"33091人(较上一季度增加0.84%)","perCapita":"9063股","listingDate":"2017-10-20","address":"重庆市荣昌区工业园区","registeredCapital":"41759万元","survey":" 重庆华森制药股份有限公司的主营业务是中成药、化学药的研发、生产和销售。公司的主要产品是耳鼻喉科用药、消化系统用药、精神神经系统用药、其他领域用药、医药商业、医药零售、其他业务。","listedPrice":4.53},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华森制药(002907)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华森制药(002907)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华森制药,002907,华森制药股票,华森制药股票老虎,华森制药股票老虎国际,华森制药行情,华森制药股票行情,华森制药股价,华森制药股市,华森制药股票价格,华森制药股票交易,华森制药股票购买,华森制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华森制药(002907)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华森制药(002907)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}